919 related articles for article (PubMed ID: 28213794)
1. Selected cytokine pathways in rheumatoid arthritis.
Noack M; Miossec P
Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.
Hu D; Tjon EC; Andersson KM; Molica GM; Pham MC; Healy B; Murugaiyan G; Pochet N; Kuchroo VK; Bokarewa MI; Weiner HL
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30639-30648. PubMed ID: 33203678
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for rheumatoid arthritis: Progress and promises.
Alghasham A; Rasheed Z
Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
5. Future therapeutic targets in rheumatoid arthritis?
Cheung TT; McInnes IB
Semin Immunopathol; 2017 Jun; 39(4):487-500. PubMed ID: 28451787
[TBL] [Abstract][Full Text] [Related]
6. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
7. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
Xu WD; Zhang M; Zhang YJ; Ye DQ
Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
[TBL] [Abstract][Full Text] [Related]
8. The roles of small-molecule inflammatory mediators in rheumatoid arthritis.
Cheng Q; Wu H; Du Y
Scand J Immunol; 2021 Mar; 93(3):e12982. PubMed ID: 33025632
[TBL] [Abstract][Full Text] [Related]
9. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis.
Kondo N; Kuroda T; Kobayashi D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681582
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
Osiri M; Wongpiyabovorn J; Sattayasomboon Y; Thammacharoenrach N
Clin Rheumatol; 2016 Jul; 35(7):1673-81. PubMed ID: 27188857
[TBL] [Abstract][Full Text] [Related]
13. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
14. TNF as a Target of Inflammation in Rheumatoid Arthritis.
Yamanaka H
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):129-34. PubMed ID: 25772178
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D enzymes facilitate IL-17- and TNFα-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF).
Friday SC; Fox DA
Immunol Lett; 2016 Jun; 174():9-18. PubMed ID: 27058440
[TBL] [Abstract][Full Text] [Related]
16. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
[TBL] [Abstract][Full Text] [Related]
17. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
19. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
Tanaka Y
Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
[TBL] [Abstract][Full Text] [Related]
20. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.
Wright HL; Bucknall RC; Moots RJ; Edwards SW
Rheumatology (Oxford); 2012 Mar; 51(3):451-9. PubMed ID: 22179732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
